Share ownership Roche Holding AG

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:31:14 2024-09-13 am EDT			5-day change	1st Jan Change
265.60 ^CHF	+0.99%		-3.84%	+8.63%

Sep. 13	FDA Approves Roche Treatment of Multiple Sclerosis Using Halozyme Delivery System	MT
Sep. 13	Roche Gets FDA Approval for Multiple-Sclerosis Treatment	DJ

Share class: Roche Holding AG

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	106,691,000	28,989,189 ( 27.17 %)	0	88.01 %
Stock B	1	702,562,700	683,197,148 ( 97.24 %)	12,464,571 ( 1.774 %)

Major shareholders: Roche Holding AG

Name	Equities	%	Valuation
Roche Holding AG 1.434 %	10,073,029	1.434 %	3 410 M CHF
MFS International (UK) Ltd. 0.5506 %	3,868,205	0.5506 %	1 309 M CHF
MFS International Singapore Pte Ltd. 0.2478 %	1,740,988	0.2478 %	589 M CHF
State Street Global Advisors Ltd. 0.2298 %	1,614,288	0.2298 %	546 M CHF
Sjunde AP-fonden 0.1445 %	1,015,509	0.1445 %	344 M CHF
Nordea Investment Management AB 0.1269 %	891,227	0.1269 %	302 M CHF
CAPFI DELEN Asset Management NV 0.1159 %	814,192	0.1159 %	276 M CHF
Amundi Asset Management SA (Investment Management) 0.1088 %	764,642	0.1088 %	259 M CHF
ACATIS Investment Kapitalverwaltungsgesellschaft mbH 0.1077 %	756,605	0.1077 %	256 M CHF
DWS CH AG 0.1027 %	721,441	0.1027 %	244 M CHF
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Saratoga Research & Investment Management 0.0429 %	2,411,121	0.0429 %	84 M CHF
Aristotle Capital Management LLC 0.0424 %	2,384,441	0.0424 %	83 M CHF
Pacer Advisors, Inc. 0.0208 %	1,167,510	0.0208 %	40 M CHF
Cardinal Capital Management, Inc. 0.008652 %	486,290	0.008652 %	17 M CHF
Boston Common Asset Management LLC 0.006391 %	359,186	0.006391 %	12 M CHF
Old National Bank (Investment Management) 0.004719 %	265,242	0.004719 %	9 M CHF
Altrius Capital Management, Inc. 0.004000 %	224,804	0.004000 %	8 M CHF
Meritage Portfolio Management, Inc. 0.003068 %	172,452	0.003068 %	6 M CHF
Port Street Investments LLC 0.002925 %	164,400	0.002925 %	6 M CHF
Chartwell Investment Partners LLC 0.002587 %	145,429	0.002587 %	5 M CHF
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Hoffmann Family 64.97 %	69,318,000	64.97 %	25 196 M CHF
Maja Oeri 7.584 %	8,091,900	7.584 %	2 941 M CHF
Severin Schwan 0.2294 %	244,786	0.2294 %	89 M CHF
zCapital AG 0.1064 %	113,500	0.1064 %	41 M CHF
State Street Global Advisors Ltd. 0.0701 %	74,772	0.0701 %	27 M CHF
Sjunde AP-fonden 0.0457 %	48,773	0.0457 %	18 M CHF
Goldman Sachs Asset Management International 0.0399 %	42,534	0.0399 %	15 M CHF
DWS CH AG 0.0289 %	30,792	0.0289 %	11 M CHF
Baloise Asset Management AG 0.0284 %	30,274	0.0284 %	11 M CHF
Evenlode Investment Management Ltd. 0.0262 %	27,991	0.0262 %	10 M CHF
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	5.36%
Roche Holding AG	1.43%
Individuals	0.02%
Unknown	93.19%

Based on 1000 largest holdings

Geographical origin of shareholders

Switzerland	2.70%
United Kingdom	1.24%
Sweden	0.33%
Germany	0.32%
Singapore	0.26%
France	0.24%
Luxembourg	0.21%
Ireland	0.16%
Italy	0.15%
Spain	0.15%
Norway	0.14%
Belgium	0.13%
Denmark	0.10%
Liechtenstein	0.09%
Austria	0.09%
Canada	0.08%
United States	0.08%
Netherlands	0.07%
Australia	0.06%
Portugal	0.05%
Finland	0.05%
New Zealand	0.03%
Individuals	0.02%
Japan	0.02%
Slovenia	0.01%
Mexico	0.01%
South Africa	0.01%
Hong Kong	0.01%

Based on 1000 largest holdings

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Employees

103,605

Sector

Pharmaceuticals

Calendar

2024-09-16 - Pharma Day

More about the company

Share ownership Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Share class: Roche Holding AG

Major shareholders: Roche Holding AG

Breakdown by shareholder type

Geographical origin of shareholders

Company Profile